Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Feng-Die,Huang ^[1] ; Yan-Ping,Zhong ^[2] ; Guang-Yu,Sun ^[1] ; Qi-Jiang,Xu ^[3] ; Zhi-Yong,Xing ^[4] ; Ke-Heng,Chen ^[1] ; Lu-Sheng,Liao ^[1] ; Ming-You,Dong ^[1]

作者单位： School of Laboratory Medicine, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China. ^[1] The Key Laboratory of Molecular Pathology (for Hepatobiliary Diseases) of Guangxi, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China. ^[2] Modern Industrial College of Biomedicine and Great Health, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China. ^[3] Chaozhou People's Hospital, Shantou University Medical College, Chaozhou, China. ^[4] School of Laboratory Medicine, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China. liaolusheng01188@ymun.edu.cn. ^[5] The Key Laboratory of Molecular Pathology (for Hepatobiliary Diseases) of Guangxi, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China. liaolusheng01188@ymun.edu.cn. ^[6]

关键词 Biomarker FANCA Immunity LIHC Prognosis

主题词人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);范科尼贫血(Fanconi Anemia);肝肿瘤(Liver Neoplasms);印迹法, 蛋白质(Blotting, Western);预后(Prognosis);范可尼贫血互补群蛋白质A(Fanconi Anemia Complementation Group A Protein)

DOI 10.1007/s10620-024-08282-3

PMID 38282187

发布时间 2024-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交